Overview of human papillomavirus (HPV) vaccination status and inhibiting factors in female students of the Faculty Of Medicine, Sam Ratulangi University
DOI:
https://doi.org/10.35790/jkkt.v13i2.65724Keywords:
vaccination status, human papillomavirus, inhibiting factorsAbstract
Background: Human Papillomavirus (HPV) is the leading cause of cervical cancer, which is a global health problem for women, especially in Indonesia. Cervical cancer ranks fourth globally and second in Indonesia as the most common cancer in women in 2022. HPV vaccination is an effective primary prevention and is part of the WHO's global cervical cancer elimination strategy. HPV immunisation in Indonesia was integrated into BIAS in 2023. Medical students are among the high-risk age groups for HPV infection and play a role as future healthcare professionals in raising public awareness about cervical cancer, HPV, and cervical cancer prevention.
Aim: To determine the status of human papillomavirus (HPV) vaccination and the inhibiting factors among female students at the Faculty of Medicine, Sam Ratulangi University.
Methods: Descriptive research with a quantitative approach and a cross-sectional design through the distribution of a Google Forms questionnaire to 276 female students from the 2025 cohort of the Faculty of Medicine at Unsrat. The analysis used is univariate analysis.
Results: A total of 114 respondents (87.8%) had not yet received the HPV vaccine, while 20 respondents (12.2%) had. The dominant barriers were not knowing where to get the HPV vaccine (67.4%), not having time for the HPV vaccine (65.3%), and not receiving a recommendation from healthcare professionals (64.6%).
Conclusion: The majority of female students in the 2025 class of the Faculty of Medicine at Unsrat had not yet been vaccinated, with the dominant barrier being not knowing where to get the HPV vaccine.
References
1. World Health Organization. Global leaders unite to accelerate cervical cancer elimination efforts. World Health Organization Western Pacific. June 19, 2025. Accessed August 4, 2025. https://www.who.int/westernpacific/news/item/19-06-2025-global-leaders-unite-to-accelerate-cervical-cancer-elimination-efforts
2. International Agency for Research on Cancer. Cervix uteri: GLOBOCAN 2022 fact sheet. Global Cancer Observatory. February 8, 2024. Accessed August 12, 2025. https://gco.iarc.who.int/media/globocan/factsheets/cancers/23-cervix-uteri-fact-sheet.pdf
3. Global cervical cancer elimination forum: advancing the call to action. World Health Organization. 2024. Accessed August 24, 2025. https://www.who.int/initiatives/cervical-cancer-elimination-initiative/cervical-cancer-forum
4. Kementerian Kesehatan Republik Indonesia. Rencana Aksi Nasional (RAN) eliminasi kanker leher rahim di Indonesia Tahun 2023-2030. Kemenkes. December 22, 2023. Accessed October 17, 2025. https://kemkes.go.id/id/rencana-aksi-nasional-ran-eliminasi-kanker-leher-rahim-di-indonesia-tahun-2023-2030
5. Wilson LA, Quan AML, Bota AB, et al. Newcomer knowledge, attitudes, and beliefs about human papillomavirus (HPV) vaccination. BMC Fam Pract. 2021;22(1):17. doi:10.1186/s12875-020-01360-1
6. World Health Organization. WHO, UNFPA mengapresiasi upaya indonesia mengeliminasi kanker serviks, mendorong strategi vaksin terpadu, dan memperkuat skrining. World Health Organization Western Pacific Indonesia. November 15, 2024. Accessed August 4, 2025. https://www.who.int/indonesia/id/news/detail/15-11-2024-who--unfpa-commend-indonesia-s-efforts-to-eliminate-cervical-cancer--urge-streamlined-vaccine-strategy-and-enhanced-screening
7. Kementerian Kesehatan Republik Indonesia. Kemenkes tegaskan komitmen eliminasi kanker serviks, 36 ribu kasus baru terdeteksi setiap tahun. Kemenkes. April 24, 2025. Accessed August 4, 2025. https://kemkes.go.id/id/kemenkes-tegaskan-komitmen-eliminasi-kanker-serviks-36-ribu-kasus-baru-terdeteksi-setiap-tahun
8. Kementerian Kesehatan Republik Indonesia. Kemenkes tambahkan 4 jenis vaksin baru untuk perlindungan anak Indonesia. Kemenkes. March 27, 2023. Accessed August 6, 2025. https://kemkes.go.id/id/%20kemenkes-tambahkan-4-jenis-vaksin-baru-untuk-perlindungan-anak-indonesia
9. UNICEF. Masa depan tanpa kanker serviks: melindungi anak perempuan Indonesia melalui imunisasi HPV. UNICEF Indonesia. January 21, 2025. Accessed August 14, 2025. https://www.unicef.org/indonesia/id/kampung-pengasuhan/kesehatan/cerita/masa-depan-tanpa-kanker-serviks-melindungi-anak-perempuan-indonesia-melalui-imunisasi-hpv
10. Sri A, Ria A Jessica R, Endang PA, Atik S. Hubungan pengetahuan kanker serviks dengan deteksi dini pemeriksaan IVA pada wanita usia subur di Kelurahan Tawaang Barat Manado. Protein. 2024;2(1):169-186. doi:10.61132/protein.v2i1.131
11. Khatiwada M, Kartasasmita C, Mediani HS, Delprat C, Van Hal G, Dochez C. Knowledge, attitude and acceptability of the human papilloma virus vaccine and vaccination among university students in Indonesia. Front Public Health. 2021;9:616456. doi:10.3389/fpubh.2021.616456
12. Alosaimi B, Fallatah D, Abd ElHafeez S, et al. Predictors of human papillomavirus (HPV) vaccine acceptability among physicians, their knowledge on cervical cancer, and factors influencing their decision to recommend it. JMDH. 2024;Volume 17:5177-5188. doi:10.2147/JMDH.S484534
13. Krisnafi ZAP, Kurniawan A, Ratih SP, Wardani HE. Motivasi mahasiswi di Sidoarjo dalam melakukan vaksinasi human papilloma virus (HPV): aplikasi model information-motivation-behavior skills. SSH. 2024;6(11):1247-1257. doi:10.17977/um062v6i112024p1247-1257
14. Fadhliana N, Malliny I, Firdus F, Rosnizar R. Imunogenitas vaksin HPV dalam pencegahan kanker serviks di Indonesia: efikasi, kebijakan, dan hambatan. JJ. 2025;12(1):77-88. doi:10.33059/jj.v12i1.11681
15. Putri A, Ragil TP, Afsy NA, et al. Pengetahuan dan sikap tentang kanker serviks dan vaksinasi HPV pada mahasiswi kampus C Universitas Airlangga. JFK. 2024;11(2):128-133. doi:10.20473/jfk.v11i2.55442
16. Human papillomavirus (HPV) vaccines. National Cancer Institute. August 15, 2024. Accessed August 14, 2025. https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-vaccine-fact-sheet
17. Pender NJ, Murdaugh CL, Parsons MA. Health promotion in nursing practice. Seventh edition. Pearson; 2015.
18. Tung WC, Corral Gonzalez I, Dawkins D, Tung HJ. Implications for home health care: perceived HPV vaccination barriers and recommended sources among Hispanic/Latino college students. Home Health Care Management & Practice. 2024;36(1):40-47. doi:10.1177/10848223231182717
19. Sudarwini NW, Parwati NWM, Indriana NPRK. Hubungan status vaksinasi human papilloma virus (HPV) dengan motivasi wanita usia subur melakukan deteksi dini kanker serviks di Klinik Ratih wilayah Unit Pelaksana Teknis Daerah Puskesmas Kuta Utara. Mal Nurse J. 2024;6(4):1623-1634. doi:10.33024/mnj.v6i4.10013
20. Krishna S, Polonijo AN. Perceived barriers and facilitators to HPV vaccination: insights from focus groups with unvaccinated mid-adults in a U.S. medically underserved area. Human Vaccines & Immunotherapeutics. 2024;20(1):2422681. doi:10.1080/21645515.2024.2422681
21. Oyedeji O, North C, Kintziger KW, et al. Understanding young adults’ perceptions regarding human papillomavirus vaccination: A qualitative study. PLoS One. 2025;20(5):e0323063. doi:10.1371/journal.pone.0323063
22. D’Errico MP, Tung WC, Lu M, D’Errico R. Barriers and recommendations associated with human papillomavirus vaccination among college students. The Journal for Nurse Practitioners. 2020;16(7):533-537. doi: 10.1016/j.nurpra.2020.04.011
23. Tsani’ah RP, Sukmanawati D, Nurasiah A. Hubungan antara tingkat pengetahuan dan dukungan tenaga kesehatan tentang kanker serviks dengan minat melaksanakan vaksin human papilloma virus (HPV) pada WUS. J Ilmu Kesehat Bhakti Husada Heal Sci J. 2024;15(01):151-159. doi:10.34305/jikbh.v15i01.1053
24. Jin SW, Lee Y, Lee S, Jin H, Brandt HM. Factors associated with college students’ human papillomavirus (HPV) vaccination and preferred strategies for catch-up vaccine promotion: a mixed-methods study. Vaccines. 2023;11(6):1124. doi:10.3390/vaccines11061124
25. Si M, Jiang Y, Su X, et al. Willingness to accept human papillomavirus vaccination and its influencing factors using information–motivation–behavior skills model: a cross-sectional study of female college freshmen in mainland China. Cancer Control. 2021;28:10732748211032899. doi:10.1177/10732748211032899
26. Mahmoud I, Al Eid MMA, Mohamed MA, Aladwani AJ, El Amin NEM. Human papillomavirus vaccination and pap test uptake, awareness, and barriers among young adults in Gulf Cooperation Council countries: a comparative cross-sectional survey. Journal of Infection and Public Health. 2024;17(10):102525. doi:10.1016/j.jiph.2024.102525
27. Goje O, Kapoor A. Meeting the challenge of vaccine hesitancy. CCJM. 2024;91(9 suppl 1):S50-S56. doi:10.3949/ccjm.91.s1.08
28. Vanderslott S, Enria L, Bowmer A, Kamara A, Lees S. Attributing public ignorance in vaccination narratives. Social Science & Medicine. 2022;307:115152. doi:10.1016/j.socscimed.2022.115152
29. Rathod S, Potdar J, Gupta A, Sethi N, Dande A. Empowering women’s health: insights into HPV vaccination and the prevention of invasive cervical cancer. Cureus. Published online November 27, 2023. doi:10.7759/cureus.49523
30. Malik S, Mock KO, Martillotti R, et al. HPV vaccines among university students: understanding barriers and facilitators of vaccine uptake. Vaccines. 2024;12(12):1385. doi:10.3390/vaccines12121385
31. Paramitha DA, Purnamasari I, Hamdan M, et al. Strategi optimalisasi program vaksinasi HPV di Kota Pekalongan. PubHealth Jurnal Kesehatan Masyarakat. 2025;4(1):37-45. doi:10.56211/pubhealth.v4i1.1007
32. Putri IA, Handayani S, Tjokroprawiro BA. Attitude and family support influenced human papilloma virus vaccination in female midwifery students. Journal of Maternal and Child Health. 2022;7(2):117-124. doi:10.26911/thejmch.2022.07.02.01
33. Salmahella D, Salim LA, Isfandiari MA. Sikap, jarak pelayanan kesehatan dan dukungan orang tua untuk kesediaan vaksinasi HPV pada remaja. JOTING. 2023;5(1):173-179. doi:10.31539/joting.v5i1.5305
34. Muthukrishnan M, Loux T, Shacham E, Tiro JA, Arnold LD. Barriers to human papillomavirus (HPV) vaccination among young adults, aged 18–35. Preventive Medicine Reports. 2022;29:101942. doi:10.1016/j.pmedr.2022.101942
35. Purwahyuni NM, Rismawan M, Wulansari NT. Studi deskriptif faktor hambatan remaja dalam melakukan vaksinasi human papillomvirus (hpv) di SMA Negeri 1 Kediri. JRKN. 2020;4(2):44-48. doi:10.37294/jrkn.v4i2.246
36. Galagali PM, Kinikar AA, Kumar VS. Vaccine hesitancy: obstacles and challenges. Curr Pediatr Rep. 2022;10(4):241-248. doi:10.1007/s40124-022-00278-9
37. Sari AD, Lutfi N, Syadida H, et al. Profil pengetahuan dan keyakinan vaksinasi hpv sebagai upaya pencegahan kanker serviks pada mahasiswi di Universitas Airlangga, Surabaya. JFK. 2020;6(1):14. doi:10.20473/jfk.v6i1.21824
38. Porajow ZC, Durry MF, Pandiangan D. Program pencegahan kanker leher rahim pada wanita kaum ibu Desa Matungkas Kecamatan Dimembe Kabupaten Minahasa Utara. Jurnal Perempuan dan Anak Indonesia. 2024;5(2):80-5. Available from URL: https://ejournal.unsrat.ac.id/v3/index.php/jpai/article/view/53280
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Cristin Gultom, Tyrsa Christine Natalia Monintja, Ronald Imanuel Ottay
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
